Women are prone to postmenopausal cancer

Women who have experienced natural menopause are at a higher risk of developing cancer, especially those who use combined hormone therapy to treat menopausal symptoms that are prone to uterine cancer and breast cancer. .

Postmenopausal women are at a higher risk of developing cancers such as ovarian, breast cancer, cervical cancer, .

Menopause occurs when a woman's ovaries stop ovulating. During natural menopause, the female body produces less hormones estrogen and progesterone, causing irregular menstruation and eventually stopping.

Menopause usually begins between the ages of 40 and 50 years. However, in many people, menopause may begin earlier if they have ever treated cancer such as surgery, chemotherapy, or hormones that cause the ovaries to stop functioning early, called early menopause. This is one of the side effects of cancer treatments.

Symptoms of menopause include hot flashes, night sweats, vaginal dryness, painful intercourse, decreased libido, osteoporosis, difficulty bladder control, mood swings and loss sleep.

Menopause and cancer risk

Most cancers usually occur between the ages of 40 and older - premenopausal age and menopause. This is the result of the aging process of the body, easily leading to errors in cell DNA , increasing the risk of cancer .

In particular, postmenopausal women are at high risk of developing cancers, such as ovarian cancer, breast cancer and uterine cancer.

The risk is greater if a woman has her menstrual period before the age of 12. The reason is, if she starts her period early, women will have longer ovulation periods, more exposure to estrogen, thereby increasing the risk. Uterine cancer and breast cancer. More ovulation than usual increases the risk of ovarian cancer.

According to researchers, using alternative hormone therapy to reduce symptoms of menopause may increase the risk of certain types of cancer.

In addition, combination hormone therapy (also called postmenopausal hormone therapy or hormone replacement therapy) helps reduce menopausal symptoms such as hot flashes and osteoporosis is thought to increase the risk of cancer.

Hormone therapy is a combination of estrogen and progestin (a form of progesterone). Studies have shown that women taking combined hormone therapy to relieve menopausal symptoms are at a higher risk of breast cancer, heart attack, stroke and blood clots. Because of these risks, doctors are often discouraged from using it for women, especially women with a history of breast cancer or those at high risk for breast cancer. Or in some cases, the doctor will prescribe low doses for a short time.

In addition, research has shown that women who receive hormone therapy despite not increasing their risk of developing lung cancer, but if they are infected, are at higher risk of dying from non-small cell lung cancer. (NSCLC). The study also found that the risk of death from lung cancer is higher than that of women who smoke and use combined hormone therapy.

Estrogen-only hormone therapy may be considered for women who have removed the uterus, because estrogen without balanced progesterone may promote endometrial growth, increasing the risk of uterine cancer.

The benefits and risks of combination hormone therapy are still controversial and research is still being done to find out more. If you are considering this method, talk to your doctor about the symptoms you are experiencing, medical history to be advised by a doctor to select and analyze benefits and risks.

Early detection of cancer germs

Women of premenopausal and menopausal age should have cancer screening to protect their health.

According to doctors, women of premenopausal and menopausal age should have a healthy diet , regular exercise , kidneys while taking hormone therapy. In particular, women aged 40 and older should check and check for cancer periodically, especially cancers such as breast, cervical, ovarian, colorectal, lung, .

Cancer screening can help detect cancer germs early on, before symptoms appear, increasing your chances of healing and long-term survival.